L
Market Data
$24.90−$10.19 (−29.04%)
LYEL · Last trade
Prev Close
$35.09
Range (28d)
$22.93 – $36.05
Recent Filings
- 8-K145.5 KBLyell Immunopharma, Inc.Dec 8, 6:02 AM ET·0001193125-25-310469
- 8-K373.5 KBLyell Immunopharma, Inc.Dec 5, 4:05 PM ET·0001193125-25-309621
- 10-Q10.8 MBLyell Immunopharma, Inc.Nov 12, 11:20 AM ET·0001628280-25-051619
- 8-K294.0 KBLyell Immunopharma, Inc.Nov 12, 11:12 AM ET·0001628280-25-051603
- 8-K178.3 KBLyell Immunopharma, Inc.Nov 10, 7:32 AM ET·0001193125-25-273269
- 8-K134.5 KBLyell Immunopharma, Inc.Nov 3, 8:30 AM ET·0001193125-25-261753
- 8-K132.8 KBLyell Immunopharma, Inc.Sep 16, 4:22 PM ET·0001193125-25-205020
- 10-Q10.1 MBLyell Immunopharma, Inc.Aug 12, 4:13 PM ET·0001806952-25-000008
- 8-K286.1 KBLyell Immunopharma, Inc.Aug 12, 4:10 PM ET·0001806952-25-000007
- 8-K523.7 KBLyell Immunopharma, Inc.Jul 25, 8:05 AM ET·0001193125-25-164853
Insiders
10- Albertson Tina M.Chief Medical Officer
- ARCH Venture Fund IX, L.P.10% Owner
- ARCH Venture Partners IX, LLC10% Owner
- ARCH Venture Partners IX, L.P.10% Owner
- Bachleda MarkDirector
- BERNS PAUL L10% Owner
- Bishop Hans EdgarDirector
- BRAWLEY OTIS WDirector
- Bulis Veronica SanchezVP, Corporate Controller
- Burow Kristina10% Owner
Tickers
Addresses
business
201 HASKINS WAY
SOUTH SAN FRANCISCO, CA, 94080
mailing
201 HASKINS WAY
SOUTH SAN FRANCISCO, CA, 94080